Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 37.25
Bid: 37.20
Ask: 37.65
Change: -0.10 (-0.27%)
Spread: 0.45 (1.21%)
Open: 37.25
High: 37.25
Low: 37.25
Prev. Close: 37.35
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TPR100 Agreement with GSK

30 Jun 2010 07:00

RNS Number : 4910O
Futura Medical PLC
30 June 2010
 



 

For immediate release

30 June 2010

 

 

 

Futura Medical plc

("Futura" or "the Company")

 

 Signs Development Agreement

with GlaxoSmithKline plc for TPR100

 

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that it has signed a development agreement with GlaxoSmithKline Consumer Healthcare (GSK) for the development of TPR100, the Company's novel, topically applied product for pain relief.

 

Under the terms of the agreement GSK will fully fund and be responsible for all clinical and regulatory development. GSK will also pay modest annual payments to Futura whilst development work proceeds. Subject to satisfactory clinical outcomes and regulatory approvals both parties expect to enter into a commercial distribution agreement in due course.

 

James Barder, Futura's Chief Executive, said: "This agreement marks another important step in the development of Futura. It broadens the Company's commercial relationships and sources of potential royalty income. In addition, it provides further endorsement of our DermaSys® drug delivery technology and of our strengths in product development."

 

 

 

 

 

 

For any further information please contact:

 

Futura Medical plc

 

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

 

 

mail to: james.barder@futuramedical.com

www.futuramedical.com

 

 

Nomura Code Securities Limited

 

Phil Walker / Giles Balleny

Tel:+44 (0)20 7776 1200

 

 

For media enquiries please contact:

 

 

 

Buchanan Communications

 

Mark Court / Stasa Filiplic / George Prassas

Tel: +44 (0) 20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

 

www.futuramedical.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRSDFSISFSSELM
Date   Source Headline
1st Apr 20207:00 amRNSFull Year Results for the year ended 31 Dec 2019
16th Mar 20207:00 amRNSNotice of Results
5th Mar 20207:00 amRNSFutura to Update on MED3000 at Investor Seminar
27th Feb 20209:37 amRNSHolding(s) in Company
17th Feb 202012:53 pmRNSHolding(s) in Company
13th Feb 20207:00 amRNSUpdate on positive EU regulatory discussions
30th Jan 20207:00 amRNSTotal Voting Rights
22nd Jan 20202:33 pmRNSRemuneration of NED and Total Voting Rights
21st Jan 20202:17 pmRNSHolding(s) in Company
21st Jan 20201:44 pmRNSHolding(s) in Company
17th Jan 202012:12 pmRNSGM Statement
7th Jan 202011:05 amRNSSecond Price Monitoring Extn
7th Jan 202011:00 amRNSPrice Monitoring Extension
27th Dec 20197:00 amRNSPosting of Circular and Notice of General Meeting
23rd Dec 20197:00 amRNSResult of Fundraising
20th Dec 20194:40 pmRNSSecond Price Monitoring Extn
20th Dec 20194:35 pmRNSPrice Monitoring Extension
20th Dec 20194:31 pmRNSPrimaryBid Offer
20th Dec 20194:30 pmRNSCorporate Update & Proposed Fundraising
17th Dec 20194:41 pmRNSSecond Price Monitoring Extn
17th Dec 20194:35 pmRNSPrice Monitoring Extension
17th Dec 201911:05 amRNSSecond Price Monitoring Extn
17th Dec 201911:00 amRNSPrice Monitoring Extension
16th Dec 20199:05 amRNSSecond Price Monitoring Extn
16th Dec 20199:00 amRNSPrice Monitoring Extension
13th Dec 20199:05 amRNSSecond Price Monitoring Extn
13th Dec 20199:00 amRNSPrice Monitoring Extension
10th Dec 20194:40 pmRNSSecond Price Monitoring Extn
10th Dec 20194:35 pmRNSPrice Monitoring Extension
10th Dec 201911:05 amRNSSecond Price Monitoring Extn
10th Dec 201911:00 amRNSPrice Monitoring Extension
10th Dec 20199:05 amRNSSecond Price Monitoring Extn
10th Dec 20199:00 amRNSPrice Monitoring Extension
10th Dec 20197:00 amRNSTop Line Results from MED2005 Phase 3 study
6th Dec 20194:10 pmRNSBlock Listing Six Monthly Return
22nd Nov 201911:48 amRNSHolding(s) in Company
20th Nov 20194:05 pmRNSHolding(s) in Company
20th Nov 20194:04 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSPublishes Fireside Chat with Prof Wayne Hellstrom
11th Nov 201912:44 pmRNSHolding(s) in Company
29th Oct 201910:03 amRNSHolding(s) in Company
28th Oct 20194:12 pmRNSMED2005 Safety and Efficacy Data Reported at SMSNA
23rd Oct 201912:46 pmRNSChange of Auditor
21st Oct 20197:00 amRNSFinal Dosing of Last Patient in MED2005 Ph3 study
15th Oct 20195:44 pmRNSFutura Medical to Present Data on MED2005 at SMSNA
15th Oct 20195:42 pmRNSDirector / PCA Shareholding
18th Sep 20195:42 pmRNSDirector/PDMR Shareholding
16th Sep 201910:11 amRNSHolding(s) in Company
13th Sep 20194:40 pmRNSSecond Price Monitoring Extn
13th Sep 20194:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.